Marc Vervloet

Diagnosis, Evaluation, Prevention, and Treatment of Chronic Kidney Disease–Mineral and Bone Disorder: Synopsis of the Kidney Disease: Improving Global Outcomes 2017 Clinical Practice Guideline Update

Markus Ketteler, Geoffrey A. Block, Pieter Evenepoel et al. · Annals of Internal Medicine · 2018 · 312 citations · Full text

Prevalence, outcomes, and cost of chronic kidney disease in a contemporary population of 2·4 million patients from 11 countries: The CaReMe CKD study

Johan Sundström, Johan Bodegård, Andreas Bollmann et al. · The Lancet Regional Health - Europe · 2022 · 303 citations · Full text

Cross Talk Between the Renin-Angiotensin-Aldosterone System and Vitamin D-FGF-23-klotho in Chronic Kidney Disease

Martin H. de Borst, Marc Vervloet, Piet M. ter Wee et al. · Journal of the American Society of Nephrology · 2011 · 276 citations · Full text

Hypertension, Renal Pathology, Vitamin D-fgf-23-klotho +16

Effects of the SGLT2 inhibitor dapagliflozin on proteinuria in non-diabetic patients with chronic kidney disease (DIAMOND): a randomised, double-blind, crossover trial

David Z.I. Cherney, Claire C. J. Dekkers, Sean J. Barbour et al. · The Lancet Diabetes & Endocrinology · 2020 · 262 citations · Full text

Renal Function, Renal Disease, Crossover Trial +7

Effects of Dietary Phosphate and Calcium Intake on Fibroblast Growth Factor-23

Marc Vervloet, Frans J. van Ittersum, Rahel M. Büttler et al. · Clinical Journal of the American Society of Nephrology · 2010 · 214 citations · Full text